Preparation method of a compound Agent derived from 5 - fluoro - 1H - pirazolopiridina； intermediaries that participate in the same compound and the final Compound Crystal forms is obtained, which is useful in the treatment of cardiocirculatory disturbances.
The present application relates to a novel and efficient process for preparing novel substituted 5-fluoro-1H-pyrazolopyridines of the formula (VI) which are suitable as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders. More particularly, the 5-fluoro-1H-pyrazolopyridines of the formula (VI) are suitable for preparation of the compound of the formula (I) which serves for production of medicaments, for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders.<；p>；La presente invenció；n se refiere a un procedimiento de preparació；n de un compuesto de fó；rmula (VI) que se prepara a partir del compuesto de la fó；rmula (V) haciendo reaccionar este compuesto con sulfolano y acetonitrilo con una posterior deshidratació；n del compuesto (V) para dar nitrito (VI), un procedimiento para preparar el compuesto de fó；rmula (I), su forma cristalina I, un procedimiento de preparació；n de la forma cristalina I； una composició；n farmacé；utica que lo comprende, y el uso del mismo en el tratamiento de trastornos cardiociculatorios.<；/p>；
